Scott+Scott Attorneys at Law LLP Reminds Investors of Federal Securities Claims Against Ripple Labs, Inc. Regarding XRP Tokens and May 20 Lead Plaintiff Deadline

Scott+Scott Attorneys at Law LLP (Scott+Scott), a national securities and consumer rights litigation firm, reminds investors that a lawsuit is pending against Ripple Labs, Inc. (Ripple Labs or the Company) and others (collectively, Defendants) regarding the violation of federal securities and other laws in connection with the sale of Ripple Labs XRP tokens (XRP), also known as Ripples. If you purchased Ripples ($XRP) between July 3, 2015 and the present, you may be eligible to recover damages and are encouraged to contact Scott+Scott attorney Rhiana Swartz at (844) 818-6980, or via email at [email protected] for more information. The lead plaintiff deadline is approaching.

The lawsuit alleges that Ripple Labs and its wholly owned subsidiary, XRP II, LLP, and certain of Ripple Labs controlling senior executives and directors violated the Securities Act of 1933 (Securities Act) as well as California state laws. The lawsuit alleges that defendants sold unregistered securities to investors in violation of Sections 5, 12(a)(1), and 15 of the Securities Act and seeks to recover damages on behalf of all purchasers of XRP.

What You Can Do

If you purchased XRP between July 3, 2015 and the present, or if you have questions about this notice or your legal rights, please contact plaintiffs counsel, Rhiana Swartz at (844) 818-6980, or via email at [email protected]. The lead plaintiff deadline is May 20, 2019.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

Rhiana Swartz
Scott+Scott
Attorneys at Law LLP

230 Park Ave, 17 Fl, NY, NY
10169-1820

(844) 818-6980
[email protected]